Loss of optineurin in vivo results in elevated cell death and alters axonal trafficking dynamics.

Abstract excerpt

Mutations in Optineurin have been associated with ALS, glaucoma, and Paget's disease of bone in humans, but little is known about how these mutations contribute to disease. Most of the cellular consequences of Optineurin loss have come from in vitro studies, and it remains unclear whether these same defects would be seen in vivo. To answer this question, we assessed the cellular consequences of Optineurin loss in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Axons
• Share to Biological Transport
• Share to Embryo, Nonmammalian